Identification of a Plasma Proteomic Signature for Lung Cancer

Inclusion Criteria

• •age ≥ 40
• •any smoking status, e.g. current, former, or never
• •co-morbid conditions, e.g. COPD
• •Nodule size ≥ 4 mm and ≤ 30 mm (up to Stage 2B eligible), any spiculation or ground glass opacity
• •Pathology: malignant - adenocarcinoma, squamous, or large cell
• •Pathology: benign - inflammatory (e.g. granulomatous, infectious) or non-inflammatory (e.g. hamartoma)
• •Clinical stage, Primary tumor: ≤T2 (e.g. 1A, 1B, 2A and 2B)
• •Clinical stage, Regional lymph nodes: N0 or N1 only
• •Clinical stage, Distant metastasis: M0 only